These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25978322)

  • 1. Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches.
    Hernández Alvarez L; Naranjo Feliciano D; Hernández González JE; Soares RO; Barreto Gomes DE; Pascutti PG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003759. PubMed ID: 25978322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
    Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
    BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach.
    Ferraro F; Merlino A; Dell Oca N; Gil J; Tort JF; Gonzalez M; Cerecetto H; Cabrera M; Corvo I
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004834. PubMed ID: 27463369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-
    Ferraro F; Merlino A; Gil J; Cerecetto H; Corvo I; Cabrera M
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31247891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.
    Robinson MW; Corvo I; Jones PM; George AM; Padula MP; To J; Cancela M; Rinaldi G; Tort JF; Roche L; Dalton JP
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1012. PubMed ID: 21483711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.
    Corvo I; Cancela M; Cappetta M; Pi-Denis N; Tort JF; Roche L
    Mol Biochem Parasitol; 2009 Sep; 167(1):41-7. PubMed ID: 19383516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening the Pathogen Box for Identification of New Chemical Agents with Anti-
    Machicado C; Soto MP; Timoteo O; Vaisberg A; Pajuelo M; Ortiz P; Marcos LA
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycans.
    Garcia-Campos A; Ravidà A; Nguyen DL; Cwiklinski K; Dalton JP; Hokke CH; O'Neill S; Mulcahy G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004688. PubMed ID: 27139907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.
    Beckham SA; Piedrafita D; Phillips CI; Samarawickrema N; Law RH; Smooker PM; Quinsey NS; Irving JA; Greenwood D; Verhelst SH; Bogyo M; Turk B; Coetzer TH; Wijeyewickrema LC; Spithill TW; Pike RN
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1601-12. PubMed ID: 19401154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of recombinant and native immunogenic forms of Fasciola hepatica proteins for serodiagnosis of sheep fasciolosis.
    Mokhtarian K; Meamar AR; Khoshmirsafa M; Razmjou E; Masoori L; Khanmohammadi M; Akhlaghi L; Falak R
    Parasitol Res; 2018 Jan; 117(1):225-232. PubMed ID: 29199372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High relatedness of bioinformatic data and realistic experimental works on the potentials of
    Fereig RM; Metwally S; El-Alfy ES; Abdelbaky HH; Shanab O; Omar MA; Alsayeqh AF
    Front Public Health; 2022; 10():1054502. PubMed ID: 36568750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Fasciola hepatica and F. gigantica in the endemic area of Guilan, Iran: Relationships between zonal overlap and phenotypic traits.
    Ashrafi K; Valero MA; Peixoto RV; Artigas P; Panova M; Mas-Coma S
    Infect Genet Evol; 2015 Apr; 31():95-109. PubMed ID: 25602718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and fibrin are novel substrates for Fasciola hepatica cathepsin L peptidases.
    Mebius MM; Op Heij JMJ; Tielens AGM; de Groot PG; Urbanus RT; van Hellemond JJ
    Mol Biochem Parasitol; 2018 Apr; 221():10-13. PubMed ID: 29414671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the active site of the collagenolytic cathepsin L3 protease of the invasive stage of Fasciola hepatica.
    Corvo I; O'Donoghue AJ; Pastro L; Pi-Denis N; Eroy-Reveles A; Roche L; McKerrow JH; Dalton JP; Craik CS; Caffrey CR; Tort JF
    PLoS Negl Trop Dis; 2013; 7(7):e2269. PubMed ID: 23875031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.